Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1

Toxicology and Applied Pharmacology

Volumn 260, Issue 3, 2012, Pages 250-259

  Hong, Gia Ming ^a,b   Bain, Lisa J ^a  

^a CLEMSON UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Arsenite; Glp; Histone; Igf 1; Myocyte; Myogenin

Indexed keywords

ARSENITE SODIUM; GLUCAGON LIKE PEPTIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE; MESSENGER RNA; METHYLTRANSFERASE; MYOGENIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR EZH2;

ACETYLATION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; LOCOMOTION; LONG TERM EXPOSURE; LOW BIRTH WEIGHT; METHYLATION; MOUSE; MYOBLAST; NEWBORN DEATH; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SPONTANEOUS ABORTION; STILLBIRTH; TRANSCRIPTION INITIATION SITE;

ANIMALS; ARSENITES; CELL LINE; GENE EXPRESSION REGULATION; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; INSULIN-LIKE GROWTH FACTOR I; MICE; MYOBLASTS; MYOGENIN; PROMOTER REGIONS, GENETIC; SODIUM COMPOUNDS;

EID: 84859942592     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.03.002     Document Type: Article

References (79)

1. Acharyya S., Sharma S.M., Cheng A.S., Ladner K.J., He W., Kline W., Wang H., Ostrowski M.C., Huang T.H., Guttridge D.C. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in Duchenne muscular dystrophy. PLoS One 2010, 5:e12479.
2. Agusa T., Kunito T., Kubota R., Inoue S., Fujihara J., Minh T.B., Ha N.N., Tu N.P., Trang P.T., Chamnan C., Takeshita H., Iwata H., Tuyen B.C., Viet P.H., Tana T.S., Tanabe S. Exposure, metabolism, and health effects of arsenic in residents from arsenic-contaminated groundwater areas of Vietnam and Cambodia: a review. Rev. Environ. Health 2010, 25:193-220.
3. Albert M., Peters A.H.F.M. Genetic and epigenetic control of early mouse development. Curr. Opin. Genet. Dev. 2009, 19:113-121.
4. Aleksic T., Chitnis M.M., Perestenko O.V., Gao S., Thomas P.H., Turner G.D., Protheroe A.S., Howarth M., Macaulay V.M. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res. 2010, 70:6412-6419.
5. Alzhanov D.T., McInerney S.F., Rotwein P. Long range interactions regulate Igf2 gene transcription during skeletal muscle differentiation. J. Biol. Chem. 2010, 285:38969-38977.
6. Andrew A.S., Bernardo V., Warnke L.A., Davey J.C., Hampton T., Mason R.A., Thorpe J.E., Ihnat M.A., Hamiltone J.W. Exposure to arsenic at levels foumd in U.S. drinking water modifies expression in the mouse lung. Toxicol. Sci. 2007, 100:75-87.
7. Arita A., Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009, 1:222-228.
8. Artaza J.N., Bhasin S., Mallidis C., Taylor W., Ma K., Gonzalez-Cadavid N.F. Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J. Cell. Physiol. 2002, 190:170-179.
9. Baccarelli A., Bollati V. Epigenetics and environmental chemicals. Curr. Opin. Pediatrics 2009, 21:243-251.
10. Barr F.D., Krohmer L.J., Hamilton J.W., Sheldon L.A. Disruption of histone modification and CARM1 recruitment by arsenic represses transcription at glucocorticoid receptor-regulated promoters. PLoS One 2009, 4:e6766.
11. Benbrahim-Tallaa L., Waalkes M.P. Inorganic arsenic and human prostate cancer. Environ. Health Perspect. 2007, 116:158-164.
12. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
13. Buchberger A., Ragge K., Arnold H.H. The myogenin gene is activated during myocyte differentiation by pre-existing, not newly synthesized transcription factor MEF-2. J. Biol. Chem. 1994, 269:17289-17296.
14. Caretti G., Di Padova M., Micales B., Lyons G.E., Sartorelli V. The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. 2004, 18:2627-2638.
15. Carvajal J.J., Rigby P.W. Regulation of gene expression in vertebrate skeletal muscle. Exper. Cell Res. 2010, 316:3014-3018.
16. Chakravarthy M.V., Davis B.S., Booth F.W. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J. Appl. Physiol. 2000, 89:1365-1379.
17. Chanda S. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol. Sci. 2006, 89:431-437.
18. Chen H., Ke Q., Kluz T., Yan Y., Costa M. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol. Cell. Biol. 2006, 26:3728-3737.
19. Cherry N. Stillbirth in rural Bangladesh: arsenic exposure and other etiological factors: a report from Gonoshasthaya Kendra. Bull. World Health Org. 2008, 86:172-177.
20. Chu F., Ren X., Chasse A., Hickman T., Zhang L., Yuh J., Smith M.T., Burlingame A.L. Quantitative mass spectrometry reveals the epigenome as a target of arsenic. Chem. Biol. Interact. 2011, 192:113-117.
21. Concha G., Vogler G., Lezcano D., Nermell B., Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 1998, 44:185-190.
22. Deato M.D., Tjian R. Switching of the core transcription machinery during myogenesis. Genes Dev. 2007, 21:2137-2149.
23. Flora S.J.S., Mehta A. Monoisoamyl dimercaptosuccinic acid abrogates arsenic-induced developmental toxicity in human embryonic stem cell-derived embryoid bodies: Comparison with in vivo studies. Biochem. Pharmacol. 2009, 78:1340-1349.
24. Fritsch L., Robin P., Mathieu J.R., Souidi M., Hinaux H., Rougeulle C., Harel-Bellan A., Ameyar-Zazoua M. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol. Cell 2010, 37:46-56.
25. Gianakopoulos P.J., Mehta V., Voronova A., Cao Y., Yao Z., Coutu J., Wang X., Waddington M.S., Tapscott S.J., Skerjanc I.S. MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells. J. Biol. Chem. 2011, 286:2517-2525.
26. Gonzalez H.O., Roling J.A., Baldwin W.S., Bain L.J. Physiological changes and differential gene expression in mummichogs (Fundulus heteroclitus) exposed to arsenic. Aquat. Toxicol. 2006, 77:43-52.
27. Guasconi V., Puri P.L. Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration. Trends Cell Biol. 2009, 19:286-294.
28. Hays A.M., Lantz R.C., Rodgers L.S., Sollome J.J., Vaillancourt R.R., Andrew A.S., Hamilton J.W., Camenisch T.D. Arsenic-induced decreases in the vascular matrix. Toxicol. Pathol. 2008, 36:805-817.
29. Juan A.H., Kumar R.M., Marx J.G., Young R.A., Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell 2009, 36:61-74.
30. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
31. Kozul C.D., Hampton T.H., Davey J.C., Gosse J.A., Nomikos A.P., Eisenhauer P.L., Weiss D.J., Thorpe J.E., Ihnat M.A., Hamilton J.W. Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. Environ. Health Perspect. 2009, 117:11805-11815.
32. Kubo Y. Comparison of initial stages of muscle differentiation in rat and mouse myoblastic and mouse mesodermal stem cell lines. J. Physiol. 1991, 442:743-759.
33. Lantz R.C., Chau B., Sarihan P., Witten M.L., Pivniouk V.I., Chen G.J. In utero and postnatal exposure to arsenic alters pulmonary structure and function. Toxicol. Appl. Pharmacol. 2009, 235:105-113.
34. Li D., Lu C., Wang J., Hu W., Cao Z., Sun D., Xia H., Ma X. Developmental mechanisms of arsenite toxicity in zebrafish (Danio rerio) embryos. Aquat. Toxicol. 2009, 91:229-237.
35. Ling Y., Sankpal U.T., Robertson A.K., McNally J.G., Karpova T., Robertson K.D. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acids Res. 2004, 32:598-610.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
37. Lu J., McKinsey T.A., Zhang C.L., Olson E.N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 2000, 6:233-244.
38. Lucarelli M. The dynamics of myogenin site-specific demethylation Is strongly correlated with its expression and with muscle differentiation. J. Biol. Chem. 2000, 276:7500-7506.
39. Luo S.W., Zhang C., Zhang B., Kim C.H., Qiu Y.Z., Du Q.S., Mei L., Xiong W.C. Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2. EMBO J. 2009, 28:2568-2582.
40. Markowski V.P., Currie D., Reave E.A., Thompson D., Wise J.P. Tissue-specific and dose-related accumulation of arsenic in mouse offspring following maternal consumption of arsenic-contaminated water. Basic Clin. Pharmacol. Toxicol. 2011, 108:326-332.
41. Marsit C.J., Karagas M.R., Danaee H., Liu M., Andrew A., Schned A., Nelson H.H., Kelsey K.T. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 2006, 27:112-116.
42. Martin C., Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 2005, 6:838-849.
43. McDonald C. Risk of arsenic-related skin lesions in Bangladeshi villages at relatively low exposure: a report from Gonoshasthaya Kendra. Bull. World Health Organ. 2007, 85:668-673.
44. McDonald O.G., Owens G.K. Programming smooth muscle plasticity with chromatin dynamics. Circ. Res. 2007, 100:1428-1441.
45. McKay B.R., O'Reilly C.E., Phillips S.M., Tarnopolsky M.A., Parise G. Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans. J. Physiol. 2008, 586:5549-5560.
46. Medrano M.A., Boix R., Pastor-Barriuso R., Palau M., Damian J., Ramis R., Del Barrio J.L., Navas-Acien A. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ. Res. 2010, 110:448-454.
47. Miyake M., Hayashi S., Sato T., Taketa Y., Watanabe K., Hayashi S., Tanaka S., Ohwada S., Aso H., Yamaguchi T. Myostatin and MyoD family expression in skeletal muscle of IGF-1 knockout mice. Cell Biol. Int. 2007, 10:1274-1279.
48. Mohammad M.M., Jack C.N., Ravi N. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ. Geochem. Health 2009, 31:189-200.
49. Musaro A., McCullagh K.J.A., Naya F.J., Olson E.N., Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999, 400:581-585.
50. Nelson J.D., Denisenko O., Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 2006, 1:179-185.
51. Ohkawa Y., Marfella C.G., Imbalzano A.N. Skeletal muscle specification by myogenin and Mef2D via the SWISNF ATPase Brg1. EMBO J. 2006, 25:490-501.
52. Ohkawa Y., Yoshimura S., Higashi C., Marfella C.G., Dacwag C.S., Tachibana T., Imbalzano A.N. Skeletal muscle specification by myogenin. J. Biol. Chem. 2007, 282:6564-6570.
53. Oikawa Y., Omori R., Nishii T., Ishida Y., Kawaichi M., Matsuda E. The methyl-CpG-binding protein CIBZ suppresses myogenic differentiation by directly inhibiting myogenin expression. Cell Res. 2011, 1-13.
54. Palacios D., Summerbell D., Rigby P.W.J., Boyes J. Interplay between DNA methylation and transcription factor availability: implications for developmental activation of the mouse myogenin gene. Mol. Cell. Biol. 2010, 30:3805-3815.
55. Ramirez T., Brocher J., Stopper H., Hock R. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. Chromosoma 2008, 117:147-157.
56. Raqib R., Ahmed S., Sultana R., Wagatsuma Y., Mondal D., Hoque A.M., Nermell B., Yunus M., Roy S., Persson L.A., Arifeen S.E., Moore S., Vahter M. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol. Lett. 2009, 185:197-202.
57. Ren X., McHale C.M., Skibola C.F., Smith A.H., Smith M.T., Zhang L. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ. Health Perspect. 2010, 119:11-19.
58. Robertson D.M., Zhu M., Wu Y.-C. Cellular distribution of the IGF-1R in corneal epithelial cells. Exp. Eye Res. 2012, 94:179-186.
59. Saccone V., Puri P.L. Epigenetic regulation of skeletal myogenesis. Organogenesis 2010, 6:48-53.
60. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 2008, 21:28-44.
61. Schnekenburger M., Talaska G., Puga A. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol. Cell. Biol. 2007, 27:7089-7101.
62. Serra C., Palacios D., Mozzetta C., Forcales S.V., Morantte I., Ripani M., Jones D.R., Du K., Jhala U.S., Simone C., Puri P.L. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol. Cell 2007, 28:200-213.
63. Shinkai Y., Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev. 2011, 25:781-788.
64. Steffens A.A., Hong G.M., Bain L.J. Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin. Toxicol. Appl. Pharmacol. 2011, 250:154-161.
65. Stummann T., Hareng L., Bremer S. Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells. Toxicology 2008, 252:118-122.
66. Sun H., Zhou X., Chen H., Li Q., Costa M. Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol. Appl. Pharmacol. 2009, 237:258-266.
67. Tachibana M., Ueda M., Takeda N., Ohta T., Iwanari H., Sakihama T., Kodama T., Hamakubo T., Shinkai Y. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 2005, 19:815-826.
68. Vahter M. Effects of arsenic on maternal and fetal health. Ann. Rev. Nutr. 2009, 29:381-399.
69. Viré E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.-M., Bollen M., Esteller M., Di Croce L., de Launoit Y., Fuks F. The polycomb group protein EZH2 directly controls DNA methylation. Nature 2006, 439:871-874.
70. von Ehrenstein O.S., Guha Mazumder D.N., Hira-Smith M., Ghosh N., Yuan Y., Windham G., Ghosh A., Haque R., Lahiri S., Kalman D., Das S., Smith A.H. Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am. J. Epidemiol. 2006, 163:662-669.
71. Wang C.H., Chen C.L., Hsiao C.K., Chiang F.T., Hsu L.I., Chiou H.Y., Hsueh Y.M., Wu M.M., Chen C.J. Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan. Toxicol. Appl. Pharmacol. 2009, 239:320-324.
72. Warsito D., Sjostrom S., Andersson S., Larsson O., Sehat B. Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF. EMBO Rep. Epub 2012.
73. Xu Q., Wu Z. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J. Biol. Chem. 2000, 275:36750-36757.
74. Yang W., Zhang Y., Li Y., Wu Z., Zhu D. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3β pathway and is antagonized by insulin-like growth factor 1. J. Biol. Chem. 2007, 282:3799-3808.
75. Yee S.P., Rigby P.W. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 1993, 7:1277-1289.
76. Yen Y.P., Tsai K.S., Chen Y.W., Huang C.F., Yang R.S., Liu S.H. Arsenic inhibits myogenic differentiation and muscle regeneration. Environ. Health Perspect. 2010, 118:949-956.
77. Yokoyama S., Asahara H. The myogenic transcriptional network. Cell. Mol. Life Sci. 2011, 10.1007/s00018-00011-00629-00012.
78. Zhou X., Sun H., Ellen T.P., Chen H., Costa M. Arsenite alters global histone H3 methylation. Carcinogenesis 2008, 29:1831-1836.
79. Zhou X., Li Q., Arita A., Sun H., Costa M. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol. Appl. Pharmacol. 2009, 236:78-84.